VVigilance Weekly공개 리포트 보기
← 이번 주 리포트
semaglutide우선순위 낮음근거 검토기타

LITERATURE DETAIL · PMID 42558052

Safety of semaglutide on depressive symptoms among people with HIV in routine clinical care.

Safety of semaglutide on depressive symptoms among people with HIV in routine clinical care.

저자
Lara Haidar, Stephanie A Ruderman, Christine Leong, Malcolm B Doupe, Catherine Lesko, Joseph A C Delaney
저널
AIDS (London, England)
공개일
2026 Aug 06
연구 유형
기타
DOI
10.1097/QAD.0000000000004598

문헌 요약

Semaglutide, widely used for diabetes and obesity, has raised concerns about neuropsychiatric risks, including depression and suicidality. Given the high burden of depression among people with HIV (PWH), we assessed whether semaglutide initiation worsens depressive symptoms. We conducted a within-person pre-post study of PWH initiating semaglutide at nine…

PV 검토 포인트

누적 안전성 근거로 분류하고 기존 시그널과의 일관성을 확인합니다.

PubMed에서 원문 정보 보기